经济与管理评论
經濟與管理評論
경제여관리평론
Shandong Economy
2015年
2期
46-52
,共7页
医药制药业%三阶段DEA模型%技术创新效率%环境影响
醫藥製藥業%三階段DEA模型%技術創新效率%環境影響
의약제약업%삼계단DEA모형%기술창신효솔%배경영향
pharmaceutical industry%three-stage DEA model%technological innovation efficiency%environmental effects
采用可以剔除环境因素和随机误差影响的三阶段DEA模型对2000－2011年我国28个省、直辖市和自治区医药制造业的技术创新效率进行实证研究，结果表明我国医药制造业技术创新效率较低，并且创新效率值会受到环境因素的影响；创新效率值较低的原因主要是纯技术效率值的低下，另外规模效率的作用也不容忽视。各地区应加大对医药制造业技术创新的投入，提高规模效率，同时完善创新管理和制度体系，以效率为导向配置创新资源，最终达到提高综合效率的目的。
採用可以剔除環境因素和隨機誤差影響的三階段DEA模型對2000－2011年我國28箇省、直轄市和自治區醫藥製造業的技術創新效率進行實證研究，結果錶明我國醫藥製造業技術創新效率較低，併且創新效率值會受到環境因素的影響；創新效率值較低的原因主要是純技術效率值的低下，另外規模效率的作用也不容忽視。各地區應加大對醫藥製造業技術創新的投入，提高規模效率，同時完善創新管理和製度體繫，以效率為導嚮配置創新資源，最終達到提高綜閤效率的目的。
채용가이척제배경인소화수궤오차영향적삼계단DEA모형대2000－2011년아국28개성、직할시화자치구의약제조업적기술창신효솔진행실증연구，결과표명아국의약제조업기술창신효솔교저，병차창신효솔치회수도배경인소적영향；창신효솔치교저적원인주요시순기술효솔치적저하，령외규모효솔적작용야불용홀시。각지구응가대대의약제조업기술창신적투입，제고규모효솔，동시완선창신관리화제도체계，이효솔위도향배치창신자원，최종체도제고종합효솔적목적。
The three-stage Data Envelopment Analysis (DEA)model can eliminate the environmental effects and random error influ-ences.Based on this model,this paper conducts an empirical study on the technological innovation efficiency of pharmaceutical indus-try,focusing on 28 provinces,municipalities,and autonomous regions in China.The results show that first technological innovation ef-ficiency of Chinese pharmaceutical industry is relatively low,and innovation efficiency values are under the influence of environmental factors.Secondly,the reason for low innovation efficiency values is mainly low pure technological efficiency.Besides,the role of scale efficiency can't be ignored.Thus,each region should invest more in technological innovation so as to improve the scale efficiency in pharmaceutical manufacturing.Meanwhile,innovative management and institutional system should be perfected and efficiency-orien-ted distribution of innovation resources should be conducted,so as to ultimately achieve the goal of enhancing innovation efficiency val-ues.
